Bank of America Corporation »

Avalo Therapeutics Ord shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-09-30 $53k 5.6k 9.50
2024-06-30 $70k 5.6k 12.47

More positions owned by Bank of America Corporation

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)

View all positions for Bank of America Corporation

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
OrbiMed Advisors
RA Capital Management
BVF
Logos Global Management
Commodore Capital
Sio Capital Management
Affinity Asset Advisors
Vanguard Group
Geode Capital Management
Bank of America Corporation
BlackRock
BlackRock
Morgan Stanley
Efficient Wealth Management

View all funds holding Avalo Therapeutics Ord